Navalign, LLC has filed a Form 13F-HR with the Securities and Exchange Commission, disclosing its equity securities portfolio as of September 30, 2026. The filing lists the firm's portfolio manager as Steve Trinh, based in Encino, California.
The report indicates that the firm holds positions in 124 distinct equity securities. The filing provides a detailed list of these holdings, including the names of the issuers, the number of shares held, and the total value of the position.
Among the largest disclosed positions in the portfolio are shares of Fidelity Merrimack Strategic Trust (Class 3) and Apple Inc., with values of approximately $11.4 million and $99,331, respectively. The filing also lists significant holdings in various exchange-traded funds, including Vanguard Star Funds, SPDR Series Trust, and iShares Trust products. Individual company holdings include major technology names such as NVIDIA Corporation, Meta Platforms Inc., Microsoft Corporation, and Visa Inc., alongside industrial and healthcare companies like Johnson Controls International, Merck & Co., and Eli Lilly & Co.
The filing includes a specific disclosure regarding a position in Allogene Therapeutics Inc., with a reported value of $49,398.
